Anxiety and Depression Among Gendarmes Posted to French Guiana

Anxiety Depression Disorder Clinical Trial

— TAD-GENDGF  

Official title:

Anxiety and Depression Among Gendarmes Posted to French Guiana (TAD-GENDGF)

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06112457
• Other study ID #: 2022PPRC07
• Secondary ID: 2023-100889-36
• Status: Not yet recruiting
• Start date: November 2023
• Est. completion date: November 2024

Study information

• Verified date: October 2023
• Source: Direction Centrale du Service de Santé des Armées
• Contact: DIA
• Phone: 0594395983
• Email: aissata.dia[@]intradef.gouv.fr
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This is a mixed-method, single-center study involving two concurrent phases: a quantitative phase with an anonymous self-administered questionnaires, and a qualitative phase with individual contextual interviews and a focus group. The hypothesis underlying this study is that isolated postings are a risk factor for anxiety-depressive disorders. The aim of this study is to provide new information to help propose targeted prevention and health promotion measures.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 600
• Est. completion date: November 2024
• Est. primary completion date: October 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Gendarme in active position
• Age over 18
• Assignment in French Guiana for more than 6 months at the time of the study
• Not opting for study participation

Exclusion Criteria:

• Previously diagnosed psychiatric condition
• People with a reading/writing disability in the French language
• Major incapacity

Related Conditions & MeSH terms

• Anxiety Depression Disorder
• Anxiety Disorders
• Depression
• Depressive Disorder

Intervention

Other:
• Survey
Anonymous self-administered questionnaire

Locations

Country	Name	City	State
French Guiana	DIASS Guyane	Cayenne	Guyane

Sponsors (1)

Lead Sponsor	Collaborator
Direction Centrale du Service de Santé des Armées

Country where clinical trial is conducted

French Guiana, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of anxiety-depressive disorders according to posting site.	Comparison of the prevalence of anxiety-depressive disorders among gendarmes posted to French Guiana according to their posting site.	Through study completion (6 months)
Secondary	Factors associated with the presence of an anxiety-depressive disorder	Evaluate factors associated with the presence of an anxiety-depressive disorder, both overall and by type of disorder	Through study completion (6 months)